USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Warszawski Uniwersytet Medyczny

USPTO PatentsView assignee record - 11 granted patents across 13 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.6

Avg claims per patent

-17%

5-year filing velocity

The verdict

Warszawski holds 11 US patents across 13 technology areas, rank #25,513 of 50,000 tracked assignees.

#25,513
of 50,000 US assignees by volume: Top 59%
by Innovation Score (32.3/100): 14.6
avg claims per patent: -17%
filing velocity, last 5 yrs

Portfolio overview

Warszawski Uniwersytet Medyczny has been granted 11 US utility patents between 2015 and 2025, placing Warszawski Uniwersytet Medyczny at rank #25,513 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Warszawski Uniwersytet Medyczny is one of the more focused assignees in the PatentsView dataset. By volume, Warszawski sits between Volm Companies, Inc. (11 patents, rank #25,509) and Wella International Operations Switzerland SARL (11 patents, rank #25,517) - the closest US assignees by grant volume. The composite Innovation Score of 32.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 6 in the 2015–2019 window, a -17% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Warszawski Uniwersytet Medyczny's 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Warszawski Uniwersytet Medyczny against peers pursuing similar technology classes.

Volm Companies

11
Voltserver

11
W Morrison Consul…

11
Warren Industries

11
Weidplas

11
Weihai Hualing Op…

11
WELL Being Digital

11
Wella Internation…

11
Warszawski Uniwer… ◀

11

What this shows Warszawski holds 11 patents at rank #25,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Warszawski's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

32 Top 59% higher than 41% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Warszawski Uniwersytet Medyczny patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	27.3%
2017	2	18.2%
2019	1	9.1%
2020	1	9.1%
2021	1	9.1%
2024	1	9.1%
2025	2	18.2%

Which technologies does Warszawski Uniwersytet Medyczny patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 8

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

C07D - HETEROCYCLIC COMPOUNDS 3

C07J - STEROIDS 2

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 1

C08J - WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H 1

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#25,513

Across all tracked assignees

Innovation Score

32.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Warszawski Uniwersytet Medyczny hold?

Warszawski Uniwersytet Medyczny holds 11 US granted patents filed between 2015 and 2025, spanning 13 technology areas.

What is Warszawski Uniwersytet Medyczny's Innovation Score?

Warszawski Uniwersytet Medyczny has an Innovation Score of 32.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Warszawski Uniwersytet Medyczny focus on?

Warszawski Uniwersytet Medyczny's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 8 patents. The company has filed patents in 13 CPC subclasses total.

Is Warszawski Uniwersytet Medyczny's patent filing rate increasing or decreasing?

Warszawski Uniwersytet Medyczny's recent filing velocity is -17% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Warszawski Uniwersytet Medyczny's patents?

Warszawski Uniwersytet Medyczny's patents average 14.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Warszawski Uniwersytet Medyczny patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Warszawski's 11 grants land it in the top 59% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Warszawski ranks #25,513 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.